1.
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse
by Du, Yingying
Vaccine, 2021, Vol.39 (16), p.2280-2287
2.
Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination
by Opriessnig, Tanja
Vaccine, 2021, Vol.39 (47), p.6852-6859
3.
Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of N...
by Belur, Lalitha R.
Human gene therapy, 2017, Vol.28 (7), p.576-587
4.
Intranasal inoculations of naked or PLGA-PEI nanovectored DNA vaccine induce systemic and mucosal antibodies in pigs: A feasibility study
by Souci, Laurent
Research in veterinary science, 2020, Vol.132, p.194-201
5.
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
by Ebensen, Thomas
Vaccine, 2011, Vol.29 (32), p.5210-5220
6.
Intranasal vaccination with ebola virus GP amino acids 258–601 protects mice against lethal challenge
by Su, Qiu-dong
Vaccine, 2018, Vol.36 (41), p.6053-6060
7.
Amphotericin B nasal lavages: Not a solution for patients with chronic rhinosinusitis
by Ebbens, Fenna A
Journal of allergy and clinical immunology, 2006, Vol.118 (5), p.1149-1156
8.
Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine
by Moriyama, Miyu
Vaccine, 2017, Vol.35 (48), p.6620-6626
9.
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Drug Liking Study on a Novel Abuse-Deterrent Formulation of Morphine—Morphine ARER
by Webster, Lynn R
Pain medicine (Malden, Mass.), 2017, Vol.18 (7), p.1303-1313
10.
Sedation effects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation
by Xie, Zhubin, RN
The American journal of emergency medicine, 2017, Vol.35 (8), p.1126-1130
11.
Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
by Mickle, Travis C Travis C
Pain medicine (Malden, Mass.), 2017, Vol.19 (12), p.2438-2449
12.
The Effects of Intranasal Oxytocin Administration on Sensitive Caregiving in Mothers with Postnatal Depression
by Mah, Beth L
Child psychiatry and human development, 2016, Vol.48 (2), p.308-315
13.
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
by Sui, Zhiwei
Vaccine, 2010, Vol.28 (48), p.7690-7698
14.
Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations
by EL-Malky, Mohamed A
Parasitology research (1987), 2014, Vol.113 (6), p.2277-2284
15.
Nasal high flow oxygen therapy in the ward setting: A prospective observational study
by Pirret, Alison M
Intensive & critical care nursing, 2017, Vol.42, p.127-134
16.
17.
Intranasal Angiotensin II in Humans Reduces Blood Pressure When Angiotensin II Type 1 Receptors Are Blocked
by Derad, Inge
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (4), p.762-767
18.
Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice
by Kammoun, Hana
Vaccine, 2012, Vol.30 (40), p.5864-5870
19.
Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update
by Luyt, Charles-Edouard
Expert review of anti-infective therapy, 2013, Vol.11 (5), p.511-521
20.
Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases
by Zhang, Jianfeng
Expert review of vaccines, 2011, Vol.10 (11), p.1539-1552
